Medicare Enrolled
Dr. Michael Tran, MD
Optician · Orange, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tran
Dr. Michael Tran is an optician specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tran performed 1,777 Medicare services across 876 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tran received a total of $13,498 from 54 pharmaceutical and/or device companies across 651 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 40% volume in CA
$13,498 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,777
Medicare services
Top 40% in CA for optician
876
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~94 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
894 | $101 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
295 | $147 | $228 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
271 | $29 | $50 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
115 | $98 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
95 | $129 | $200 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
27 | $52 | $100 |
| Functional capacity test, per 15 minutes A test or measurement to assess functional capacity. The service is billed for each 15-minute increment. |
22 | $26 | $52 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
20 | $77 | $170 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
14 | $136 | $200 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
12 | $121 | $200 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
12 | $52 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,498
Total received (2018-2024)
Avg $1,928/year across 7 years
Top 11% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
651
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,498 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,604
2023
$2,145
2022
$1,422
2021
$1,745
2020
$1,111
2019
$3,535
2018
$1,935
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$229
Lilly USA, LLC
$203
Amgen Inc.
$165
ABBVIE INC.
$138
Radius Health, Inc.
$118
Abbott Laboratories
$103
Xeris Pharmaceuticals, Inc.
$81
Antares Pharma, Inc.
$72
Insulet Corporation
$60
RECORDATI_RARE_DISEASES_INC.
$56
Corcept Therapeutics
$55
Ethicon Endo-Surgery Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Embecta Corp.
$44
Dexcom, Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$37
Averitas Pharma Inc.
$26
Ascensia Diabetes Care Us Inc.
$25
Medtronic, Inc.
$21
IBSA Pharma Inc.
$19
Mannkind Corporation
$14
Top 3 companies account for 37.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,829
Medtronic MiniMed, Inc.
$1,807
SANOFI-AVENTIS U.S. LLC
$1,223
Novo Nordisk Inc
$1,046
Amgen Inc.
$729
AstraZeneca Pharmaceuticals LP
$581
Insulet Corporation
$405
Radius Health, Inc.
$396
Medtronic, Inc.
$395
Boehringer Ingelheim Pharmaceuticals, Inc.
$388
MannKind Corporation
$345
Janssen Pharmaceuticals, Inc
$288
Abbott Laboratories
$282
Xeris Pharmaceuticals, Inc.
$280
Mannkind Corporation
$243
AbbVie Inc.
$231
Dexcom, Inc.
$220
AbbVie, Inc.
$219
Becton, Dickinson and Company
$193
Bayer Healthcare Pharmaceuticals Inc.
$181
Alexion Pharmaceuticals, Inc.
$173
ABBVIE INC.
$154
Pharmacyclics LLC, An AbbVie Company
$146
Horizon Therapeutics plc
$127
Antares Pharma, Inc.
$125
Merck Sharp & Dohme Corporation
$120
CeQur Corporation
$116
Corcept Therapeutics
$110
Embecta Corp.
$109
RECORDATI_RARE_DISEASES_INC.
$104
IBSA Pharma Inc.
$90
DEXCOM, INC.
$72
Novartis Pharmaceuticals Corporation
$69
COVIDIEN LP
$63
Covidien LP
$61
Ethicon Endo-Surgery Inc.
$53
Aytu BioScience, Inc
$51
Tandem Diabetes Care, Inc.
$42
Acerus Pharmaceuticals Corporation
$38
Merck Sharp & Dohme LLC
$37
Supernus Pharmaceuticals, Inc.
$36
Shire North American Group Inc
$36
Stryker Corporation
$35
Ultragenyx Pharmaceutical Inc.
$34
Ethicon US, LLC
$30
Gemini Laboratories, LLC
$30
Averitas Pharma Inc.
$26
Ascensia Diabetes Care Us Inc.
$25
Amneal Pharmaceuticals LLC
$25
Bigfoot Biomedical Inc
$24
Zealand Pharma US, Inc.
$19
Amryt Pharma Holdings Ltd
$16
Amphastar Pharmaceuticals, Inc.
$14
Regeneron Healthcare Solutions, Inc.
$11
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CeQur Simplicity · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Echelon; Endopath · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · IMBRUVICA · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LICART · LIGASURE · LYUMJEV · LigaSure · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Natesto · Omnipod · Ozempic · PRALUENT · ProGrip · Prolia · QUTENZA · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,034
Per 100K population
32.7
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tran is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tran experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tran performed 894 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $13,498 from 54 companies across 651 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other opticians in Orange?
Dr. Tran's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Orange
Browse opticians in Orange ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Medtronic MiniMed, Inc. Payments to Doctors
See all physicians who received payments from Medtronic MiniMed, Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology